Skip to main content

Day: March 18, 2021

L Brands Announces Board of Directors Changes

– APPOINTS FRANCIS A. HONDAL AND DANIELLE LEE TO BOARD OF DIRECTORS –– LES AND ABIGAIL WEXNER WILL NOT STAND FOR REELECTION TO BOARD IN MAY 2021 –COLUMBUS, Ohio, March 18, 2021 (GLOBE NEWSWIRE) — L Brands, Inc. (NYSE: LB) today announced that Francis Hondal, president of loyalty and engagement at Mastercard, and Danielle Lee, Chief Fan Officer for the National Basketball Association, have been appointed as two new independent members of its Board of Directors. Additionally, Les and Abigail Wexner will not stand for reelection to the Board at the annual shareholders’ meeting in May 2021. With these changes, in May 2021, the Board will consist of 10 directors, nine of whom are independent and six of whom are women (including the Chair of the Board).Les Wexner said “L Brands is at a terrific place in its history. The Board is incredibly...

Continue reading

Cytokinetics Announces Secondary Analysis From GALACTIC-HF to Be Presented in Late Breaking Clinical Trial Session at American College of Cardiology 70th Annual Scientific Session & Expo (ACC.21)

SOUTH SAN FRANCISCO, Calif., March 18, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that data from a secondary analysis of GALACTIC-HF (Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure) assessing the effect of omecamtiv mecarbil on clinical outcomes in relationship to patient baseline ejection fraction will be presented in a Late Breaking Clinical Trial session at the American College of Cardiology 70th Annual Scientific Session & Expo (ACC.21) by John Teerlink, M.D., Professor of Medicine, University of California San Francisco, Director of Heart Failure, San Francisco Veterans Affairs Medical Center and Executive Committee Chair, GALACTIC-HF.Title: 410-16 Impact Of Ejection Fraction On The Therapeutic Effect Of Omecamtiv Mecarbil In...

Continue reading

Azucar Hits 43.55 metres of 0.37 g/t Gold and 0.21% Copper at the Porvenir Zone at the El Cobre Project, Mexico

VANCOUVER, British Columbia, March 18, 2021 (GLOBE NEWSWIRE) — Azucar Minerals Ltd. (“Azucar” or the “Company”) (TSX-V: AMZ; OTCQX: AXDDF) is pleased to announce results from drilling at the Porvenir Zone at the El Cobre porphyry copper-gold project in Veracruz State, Mexico. The now complete additional drilling carried out at Porvenir helps define the geologic boundaries and distribution of copper and gold in this zone for geologic modelling. A plan showing the location of the Porvenir Zone updated with the new results is attached to this news release. The El Cobre project covers a large area of porphyry style alteration with numerous zones of copper-gold mineralisation identified by past work. Highlights of the new drilling in the Porvenir Zone include the following intervals:Hole EC-20-110   EL PORVENIR...

Continue reading

Collection Sites Launches Business to Business Sales Initiatives; Provides Update With February Sales of 30,717 Tests at an Average Price of $98 per Test

TORONTO, March 18, 2021 (GLOBE NEWSWIRE) — Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) is pleased to provide investors with a sales update and announces the launch of a new business to business sales strategy, including the initiative of two custom testing solutions.On Monday, March 8th, 2021, Collection Sites launched two multi-week custom COVID-19 testing programs as part of its new business-focused testing services. Moving forward, Collection Sites will be dedicating additional efforts to securing testing contracts with businesses across the United States to provide custom testing solutions.The first program is with a TV & Film production studio based in Los Angeles, where Collection Sites staff provide 24 hour PCR test results on-site for crew, talent and staff in accordance with the required COVID-19 testing...

Continue reading

Ocugen Provides Business Update and Full Year 2020 Financial Results

Conference Call and Webcast Today at 8:30 a.m. ETCOVID-19 vaccine candidate, COVAXIN™, demonstrates efficacy of 81% in Phase 3 interim resultsEmergency Use Authorization pathway with U.S. regulatory authorities in development for COVAXIN™European Commission grants orphan medicinal product designation for OCU400 for retinitis pigmentosa and leber congenital amaurosis and Ocugen is on track to submit an Investigational New Drug application for OCU400 in 2021On track to initiate four Phase 1/2 clinical trials encompassing Ocugen’s ophthalmology pipeline in 2021 and 2022MALVERN, Pa., March 18, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen”) (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19,...

Continue reading

Dual Chamber Prefilled Syringes Market Size to Reach USD 223.3 Million By 2028: CAGR of 7.0% | Reports And Data

New York, March 18, 2021 (GLOBE NEWSWIRE) — Growing demand for advanced devices to provide controlled drugs is a significant factor influencing growth of the market.The global dual chamber prefilled syringes market is expected to be valued at USD 223.3 million by end of 2028 from a value of USD 130 million in 2020, expanding at a CAGR of 7% over the forecast period. The dual chamber prefilled syringes are increasingly witnessing adoption from research & development activities initiated for introducing improved drugs for the several chronic diseases such as diabetes. According to the data published by World Health Organization (WHO), diabetes is becoming seventh leading cause of death. The mortality from diabetes from 2000 to 2016 has increased to 5% and counted for 1.6 million deaths in 2016. The increasing number of patients...

Continue reading

Nuvei Announces US$494 Million Bought Deal Secondary Offering

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESMONTREAL, March 18, 2021 (GLOBE NEWSWIRE) — Nuvei Corporation (“Nuvei” or the “Company”) (TSX: NVEI and NVEI.U), the global payment technology partner of thriving brands, has announced today that funds managed by Novacap Management Inc. (collectively, “Novacap”), Whiskey Papa Fox Inc., a holding company controlled by Philip Fayer, our Chair and Chief Executive Officer (“Fayer Holdco”), CDP Investissements Inc., a wholly-owned subsidiary of Caisse de dépôt et placement du Québec (“CDPQ”) and David Schwartz, our Chief Financial Officer (together the “Selling Shareholders”), and the Company have entered into an agreement with Goldman Sachs Canada Inc., Credit Suisse, BMO Capital Markets and RBC Capital Markets to complete a secondary offering on...

Continue reading

Hexagon Agility receives third set of orders for CNG trucks from major global logistics customer

Hexagon Agility, a business of Hexagon Composites, signed a master services agreement in June 2020 with a global logistics customer to deliver compressed natural gas (CNG) fuel systems for medium and heavy-duty trucks.Hexagon Agility received its third set of orders in 2021 under this agreement, which represent an estimated total value of USD 5.9 million (approx. NOK 50 million).Collectively the orders placed in 2021 represent an estimated total value of USD 19.4 million (approx. NOK 165 million).“The strong momentum of orders coming in as we kick off 2021 reflect the forward leaning approach of this global logistics customer. CNG and RNG play an important role in the future of commercial trucking. Sustainable fleets makes both environmental and economic sense to deploy natural gas trucks right now – and make it possible to...

Continue reading

Aktia Suomen paras rahastotalo Morningstar-vertailussa

Aktia Pankki OyjLehdistötiedote18.3.2021Aktia on voittanut Morningstarin Suomen Awards 2021 -kilpailussa rahastotalojen kaikki kolme kärkisijaa.Rahastotalojen osalta vertailussa tarkastellaan viiden vuoden riskikorjattua tuottoa kolmella eri osa-alueella: osake-, korko- ja yhdistelmärahastot. Tänä vuonna Aktia vei voiton kaikilla kolmella osa-alueella.”Menestys Morningstar-vertailussa kertoo pitkäjänteisestä työstämme varainhoidon saralla. Aktialla on ainutlaatuinen osaaminen niin koroissa kuin osakkeissa ja tuotamme lisäarvoa asiakkaillemme monipuolisella tarjoamallamme. On jälleen kerran hienoa saada työllemme tunnustusta”, sanoo Aktia Pankin varainhoidosta vastaava johtaja Niina Bergring.Aktian rahastojen menestys ja korkealuokkainen varainhoito on kaikkien asiakkaiden hyödynnettävissä institutionaalisista sijoittajista henkilöasiakkaisiin.Niina...

Continue reading

Aktia Finlands bästa fondhus i Morningstars jämförelse

Aktia Bank AbpPressmeddelande18.3.2021Aktia har placerat sig på topp i alla fondhuskategorier i Morningstars Finland Awards 2021-tävling.I fråga om fondhus granskas i jämförelsen den riskjusterade avkastningen under fem års tid på tre olika delområden: aktier, räntor och kombinationsfonder. I år tog Aktia hem segern på alla tre delområden.”Framgången i Morningstar-jämförelsen talar om vårt långsiktiga kapitalförvaltningsarbete. Aktia har unik kompetens inom såväl räntor som aktier och vi skapar mervärde för våra kunder genom vårt mångsidiga utbud. Det är återigen fint att få erkännande för vårt arbete”, säger Niina Bergring, direktör med ansvar för kapitalförvaltningen i Aktia Bank.Aktias fonders framgång och den högklassiga kapitalförvaltningen är tillgänglig för samtliga kunder från institutionella placerare till privatkunder.Niina...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.